Clinical Trials Logo

Filter by:
NCT ID: NCT05875857 Enrolling by invitation - Opioid Use Clinical Trials

Patient Utilization of Opioid Destruction Bags in the Post op Period

Start date: June 19, 2023
Phase: N/A
Study type: Interventional

This is a study on how patients use and store opioid pain medications at home after surgery and what happens to left over pills when patients are done taking them. Participants will be taught the proper storage and destruction of opioid pain medications, then contacted in 6-8 weeks about pain medication used, stored disposed of.

NCT ID: NCT05874102 Enrolling by invitation - Aspiration Clinical Trials

The Effect of Body Position on Oropharyngeal Swallow Function in Infants

Start date: January 13, 2023
Phase: N/A
Study type: Interventional

Infants are typically fed in a cradled, upright position, however feeding specialists/SLPs often position infants in a side-lying position to promote safe, quality, and neurodevelopmentally protective feeding which is supported by currently available literature. Side-lying position is often recommended by feeding specialists to reduce the risk for aspiration and improve other components of infant swallow function. However, there is no literature directly assessing airway protection during the swallow with the infant in the side-lying versus upright positions. The goal of this study is to conduct an instrumental assessment (Modified Barium Swallow/Videofluoroscopic Swallow Study) in these different positions (upright versus side-lying) to determine if there is a difference in airway compromise. The target population are infants between post-menstrual ages of 38-56 weeks who are referred for a modified barium swallow study.

NCT ID: NCT05873660 Enrolling by invitation - Obesity Clinical Trials

A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease.

POETIC
Start date: June 12, 2023
Phase:
Study type: Observational

The purpose of this observational study is to measure how many people are overweight or obese amongst patients with a diagnosed cardiovascular disease (CVD). The study also aims to characterise the population including the presence of cardiovascular (CV) risk factors in a number of countries across the globe representing different geographies, ethnicities, as well as different healthcare systems.

NCT ID: NCT05872022 Enrolling by invitation - Obesity Clinical Trials

A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy

Start date: July 5, 2023
Phase:
Study type: Observational

This is an observational, prospective Wegovy (semaglutide 2.4 milligram [mg]) Pregnancy Registry Study. The aim of this study is to compare the maternal, foetal, and infant outcomes of pregnant women who are exposed to Wegovy during pregnancy for the treatment of obesity or overweight with at least one weight-related comorbid condition with outcomes in an internal comparison cohort of pregnant women with obesity or overweight with at least one weight related comorbid condition at conception and who are not exposed to Wegovy or other glucagon-like peptide-1 receptor agonists (GLP-1 RAs) during pregnancy. Infant outcomes will be assessed throughout the infant's first year of life, with active data collection by the registry occurring at 4 and 12 months after delivery.

NCT ID: NCT05871125 Enrolling by invitation - Breast Cancer Clinical Trials

Identifying Ideal Reimbursement "Dose" to Reduce Clinical Trial-related Financial Toxicity

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to identify the recommended financial reimbursement amount for women with breast cancer enrolled in a clinical trial. The main questions it aims to answer are: 1. What is the recommended financial reimbursement amount in trial-enrolled women with breast cancer experiencing financial toxicity? 2. What do patients think about receiving a reimbursement for trial-incurred expenses? Participants will receive a monthly reimbursement to compensate for their trial-incurred expenses in cohorts, which will de-escalate for the next participant cohort if patients find the reimbursement dose suitable (negative financial toxicity screen, reimbursement dose deemed acceptable/appropriate). Researchers will also use qualitative interviews to explore patient perceptions of the trial reimbursements.

NCT ID: NCT05870527 Enrolling by invitation - Hearing Loss Clinical Trials

Pupillary Dilation During Post-Auricular Vagal Nerve Stimulation

Start date: July 10, 2023
Phase: N/A
Study type: Interventional

The research team will evaluate pupillary dilation from vagal nerve stimulation of Arnold's Nerve, a branch of the vagus nerve, during routine cochlear implantation surgery.

NCT ID: NCT05870176 Enrolling by invitation - Cancer Clinical Trials

ActivityChoice: Implementing Clinic-Based Physical Activity Program Choices for Cancer Survivors

Start date: September 11, 2023
Phase: N/A
Study type: Interventional

Cardiovascular disease, the number one leading cause of death in the United States, is highly prevalent in cancer survivors. Physical activity can reduce risk, and referrals to programs addressing survivors' choices are highly recommended from providers in cancer survivorship, though rarely implemented. The study team proposes to develop ActivityChoice, a clinic-based implementation program, using patient narrative decision aids to support choices to a group in-person, group virtual, or self-monitored digital health physical activity program.

NCT ID: NCT05868954 Enrolling by invitation - Diet, Healthy Clinical Trials

Implementation of a Mediterranean Diet Program for Overweight or Obese Pregnant Women in a Low-resource Clinical Setting

MedDiet
Start date: August 31, 2023
Phase: N/A
Study type: Interventional

The purpose of this research is to compare two healthy diet styles during pregnancy. Sixty pregnant women between 8 and 16 weeks will participate. Participates will be randomly assigned (like flipping a coin) to either receive routine healthy diet advice and counseling, or to receive advice and counseling for the Mediterranean style diet. Our current routine healthy diet program follows the recommendations provided by the American College of Obstetricians and Gynecologists (ACOG). It recommends the consumption of grains, fruits, vegetables, protein foods, and dairy foods during pregnancy. The Mediterranean diet (MedDiet) is a well-known healthy diet that consists of a large amount of plant-based foods such as fruits, vegetables, beans, and nuts with olive oil as the principal source of fat. Dairy, fish, and poultry are consumed in moderation and red meat only eaten occasionally. Throughout their pregnancy, participants will receive free food and be assessed to determine how will they are following to the diet plan they were randomized to.

NCT ID: NCT05867628 Enrolling by invitation - Cerebral Palsy Clinical Trials

Intensive Activities-based Locomotor Training Program in Children With Cerebral Palsy

Start date: February 1, 2023
Phase:
Study type: Observational

The goal of the proposed work is to investigate the impact of an intensive 3-week activities-based locomotor training (AB-LT) program on activity capacity, activity performance, and participation in children with cerebral palsy (CP). Caregiver perspectives will provide a holistic assessment of the program.

NCT ID: NCT05866952 Enrolling by invitation - Dyspnea Clinical Trials

Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection

PASC VQ
Start date: June 5, 2023
Phase:
Study type: Observational

Prospective cohort study to evaluate the utility of quantitative CT analysis to assess ventilation and perfusion defects in patients with Post-acute Sequelae of SARS-CoV-2 (PASC) and functional limitations